HeartBeam

Q2 FY2026 EarningsQ2 FY26 missed consensus on top-line and operating results: zero revenue was generated vs. $80K expected, as the HeartBeam System remains in a limited commercial launch phase. The GAAP net loss of $5.04M was wider than the $4.71M consensus, and EPS of -$0.10 missed the -$0.09 mean expectation. Despite a strategic shift towards IP licensing, substantial doubt about the company's ability to continue as a going concern persists due to an $8.7M cash balance insufficient to fund the next 12 months.